Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava plc (NYSE: DAVA) reported weaker‑than‑expected first‑quarter fiscal 2026 results before the U.S. market open today and cut its full‑year guidance. Shares fell sharply in early trading as investors digested a year‑over‑year revenue decline and softer outlook; the company also announced an expanded multi‑year partnership with Toyota Racing Development (TRD U.S.A.). Business Wire


Quick takeaways

  • Q1 FY26 revenue: £178.2M, –8.6% y/y (–7.3% constant currency).
  • IFRS diluted EPS:£(0.15); Adjusted diluted EPS:£0.15.
  • FY26 outlook cut: revenue now £735–£752M (cc –4.5% to –2.5%); adjusted EPS £0.80–£0.88.
  • New deal flow: CEO flagged a multi‑year payments deal “up to $100M.”
  • Brand expansion: TRD U.S.A. names Endava Official IT Consulting Partner for 2026+, expanding into IMSA. Endava plc

By the numbers: Q1 FY26 (quarter ended Sept 30, 2025)

  • Revenue: £178.2M (vs. £195.1M a year ago), –8.6%; –7.3% at constant currency.
  • Loss before tax: £(8.5)M (vs. +£4.2M).
  • Adjusted PBT: £9.9M (5.5% margin) vs. £19.2M (9.9%).
  • IFRS diluted EPS: £(0.15); Adjusted diluted EPS: £0.15 (vs. £0.25).
  • Cash from operations: £12.3M; Adjusted free cash flow: £9.2M.
  • Cash & equivalents (Sept 30): £47.2M. Business Wire

Business mix & clients. Endava ended the quarter with 11,636 total headcount; 133 clients generated over £1M on a rolling‑12‑month basis. Revenue mix: North America 42%, UK 28%, Europe 24%, RoW 6%. By industry: BCM 22%, Payments 17%, TMT 17%, Healthcare 12%, Mobility 9%, Insurance 9%, Other 14%. Business Wire


What management said

CEO John Cotterell noted results were “lower than guided primarily due to an unexpected credit made to a client” and slower conversion of some pipeline opportunities. He added Endava has secured a multi‑year strategic relationship with a leading payments company “of up to $100 million.” Business Wire


Outlook: Q2 and FY26 guidance (and how it changed)

  • Q2 FY26 (Dec quarter): revenue £179–£182M (cc –8% to –7% y/y); adjusted diluted EPS £0.15–£0.17. Business Wire
  • FY26 (year to June 2026): revenue £735–£752M (cc –4.5% to –2.5% y/y); adjusted diluted EPS £0.80–£0.88. Business Wire

Versus September guidance: On Sept 4, Endava guided FY26 revenue to £750–£765M and adjusted EPS £0.82–£0.94; today’s ranges are lower on both revenue and earnings. Business Wire

Capital returns. As of Oct 31, Endava had repurchased ~7.14M ADSs for $115.9M, with $34.1M left under its authorization. Endava plc


Stock reaction

Pre‑market headlines flagged a double‑digit drop on the miss and reduced guidance; early reports showed declines exceeding 20% before the open.

Street & consensus context

Several trackers noted the quarter missed consensus on both EPS and revenue. Investing.com highlighted adjusted EPS of £0.15 vs. £0.18 expected and revenue of £178.2M vs. ~£188.8M expected. Zacks similarly called out a shortfall versus its EPS consensus. Investing


New today: TRD U.S.A. partnership expands

Separately, TRD U.S.A. (Toyota Racing Development) announced a multi‑year expanded partnership naming Endava its Official IT Consulting Partner in 2026 and beyond, with Endava’s presence extending into IMSA next season. TRD cited plans to leverage Endava’s AI‑enabled accelerators to modernize core production systems. Business Wire


Sector exposure snapshot

The quarter’s mix underscores Endava’s tilt toward financial services (Payments + BCM = ~39%) and TMT, with North America now the largest geography (42%) and the Top 10 clients at 36% of revenue. While order timing remains a headwind, management’s mention of a large payments deal and ongoing share repurchases are near‑term offsets. Business Wire


Key dates to watch

Endava is slated to present at multiple investor conferences over the next month, including the Morgan Stanley 25th European TMT Conference (Nov 13, Barcelona), J.P. Morgan Ultimate Services (Nov 18), Needham Tech Week (Nov 21), UBS Global Technology & AI (Dec 2–3) and TD Cowen IT Services & Digital Engineering Summit (Dec 9). Endava plc

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Ipsen Partners with Origami to Expand Rare Disease Pipeline; Shares Seen as Undervalued
    February 1, 2026, 1:59 AM EST. Ipsen (ENXTPA:IPN) announced a global collaboration and option agreement with Origami Therapeutics to develop a novel small molecule for a rare neurodegenerative disorder. This move aligns with Ipsen's focus on rare diseases and neuroscience, aiming to deliver first or best in class therapies. Shares are currently trading about 3.7% above the €132.73 consensus target but flagged as 30.8% undervalued by Simply Wall St's analysis. The stock shows strong short-term momentum with an 18.5% 30-day return. Key risks include execution challenges and reduced profit margins, which fell to 11.9% from 19.3% last year. Investors should monitor clinical milestones and valuation shifts as the program progresses.
Enphase Energy (ENPH) News Today — Nov. 11, 2025: CEO Buys More Shares, Fresh Institutional Stakes Emerge, and EV Charger 2 Shipments Start Next Week
Previous Story

Enphase Energy (ENPH) News Today — Nov. 11, 2025: CEO Buys More Shares, Fresh Institutional Stakes Emerge, and EV Charger 2 Shipments Start Next Week

Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025
Next Story

Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

Go toTop